F Valensi

5.5k citations
27 papers · 1.7k indexed · 1 hit paper · h-index 11

Impact in

  • Hematology top 1%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Platelet Disorders and Treatments
    • Antioxidant Activity and Oxidative Stress

Papers in

    • Acute Myeloid Leukemia Research 9
    • Chronic Myeloid Leukemia Treatments 3
    • Chronic Lymphocytic Leukemia Research 4
    • Genomic variations and chromosomal abnormalities 2

F Valensi

26 papers receiving 1.6k citations

Hit Papers

NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3) 1991 · 786 citations
7861991202620022014250500750

Peers

F Valensi
Comparison fields: 5 of 80
  • Hematology 936
  • Biochemistry 149
  • Genetics 234
  • Immunology 313
  • Molecular Biology 1.0k
Replace Dario Ferrero with:
Dario Ferrero Italy
Robert L. Redner United States
Emanuela Ottaviani Italy
Carmela Gurrieri Italy
SR Frankel United States
Anja Vales Austria
Heike Engel United States
Gianfranco Catalano Italy
Juraj Bodo United States
Magdalena Plašilová United States
F Valensi relative to Dario Ferrero Italy Dario Ferrero's profile →
Citations per field
00.5×3.0×
Dario Ferrero · 1×
Citations per year

Countries citing papers authored by F Valensi

Since Specialization
Citations

This map shows the geographic impact of F Valensi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Valensi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Valensi more than expected).

Fields of papers citing papers by F Valensi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Valensi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Valensi. The network helps show where F Valensi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside F Valensi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F Valensi Line = papers co-authored together F Valensi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 199669
2 19963
3
Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies.
1995165
4 19912
5
NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
Hit paper breakdown →
1991786
6 199170
7
T cell receptor delta gene rearrangements occur predominantly in immature myeloid leukemias exhibiting lineage promiscuity.
199023
8 19899
9
Are most secondary acute lymphoblastic leukemias mixed acute leukemias?
19893
10
Philadelphia-positive acute leukemia: lineage promiscuity and inconsistently rearranged breakpoint cluster region.
198853
11 1987130
12
Peripheral T cell lymphoma following angioimmunoblastic lymphadenopathy.
19872
13
Cytogenetic studies of 32 malignant lymphomas with special emphasis to variation of chromosomal abnormalities and significance of normal mitoses
19852
14
[Thrombocythemia with Philadelphia chromosome. Secondary appearance of chronic myeloid leukemia].
19831
15
Karyotype and cell phenotypes in primary acute leukemias.
198110
16
[Induced leukemias. Cytogenetical and cytological aspects. Comparison with primitive leukemias (author's transl)].
19817
17
Karyotypes and cell phenotypes in acute leukemia following other diseases.
19812
18
[Translocation t (8; 21) and acute granulocytic leukemia: interpretation of normal mitoses].
19810
19
[T (15;17) translocation in acute promyelocytic and acute nonpromyelocytic leukemia (author's transl)].
19793
20
Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.
1976148

About F Valensi

F Valensi is a scholar working on Hematology, Genetics, Internal Medicine, Public Health, Environmental and Occupational Health and Immunology, having authored 27 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (6 papers), Retinoids in leukemia and cellular processes (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), T-cell and Retrovirus Studies (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Genomic variations and chromosomal abnormalities (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Hematology (936 citations), Biochemistry (149 citations), Genetics (234 citations), Immunology (313 citations) and Molecular Biology (1.0k citations). F Valensi has collaborated with scholars based in France and United States. Frequent co-authors include Michel Lanotte, Stevo Najman, Roland Berger, R Berger, Alain Bernheim, F Sigaux, Georges Flandrin, Nicole Brousse, D Leboeuf and Muhammad Taher. Their work appears in journals such as Blood, Journal of the American Academy of Dermatology, The Journal of Immunology, Cancer Genetics and Cytogenetics and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026